TENECTEPLASE Side Effects

6649408-4 | Coronary Artery Dissection
on Mar 10, 2010 Female patient from GERMANY , 65 years of age, was diagnosed with myocardial infarction, parkinson's disease (What is parkinson's disease?), hypertension and was treated with Tenecteplase (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery dissection. Tenecteplase dosage: . During the same period patient was treated with PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), SINEMET (View Sinemet Review and Sinemet Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), RASAGILINE (View Rasagiline Review and Rasagiline Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ).

6457430-6 | Coronary Artery Stenosis
Patient was taking Tenecteplase (View Usage). Patient had the following side effects: coronary artery stenosis on Nov 12, 2009 from GERMANY Additional patient health information: Male patient , weighting 198.4 lb, was diagnosed with percutaneous coronary intervention and. Tenecteplase dosage: Unk. During the same period patient was treated with ENOXAPARIN SODIUM (Unk) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), CLOPIDOGREL (Unk) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6449728-2 | Cerebral Artery Embolism, Cerebral Ischaemia, Hemiparesis
Adverse event was reported on Nov 10, 2009 by a Male patient taking Tenecteplase (View Usage) (Dosage: 10000 Unit, Unk) was diagnosed with thrombosis and. Location: GERMANY , 66 years of age, After Tenecteplase was administered, patient had the following side effects: cerebral artery embolism, cerebral ischaemia, hemiparesis.

6443820-4 | Cerebral Artery Embolism, Cerebral Ischaemia, Hemiparesis
on Nov 04, 2009 Male patient from GERMANY , 66 years of age, was diagnosed with thrombosis and was treated with Tenecteplase (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral artery embolism, cerebral ischaemia, hemiparesis. Tenecteplase dosage: 10000 Unit, Unk.


6429300-0 | Coronary Artery Stenosis
on Oct 29, 2009 Male patient from GERMANY , weighting 198.4 lb, was treated with Tenecteplase (View Usage). Patient had the following side effects: coronary artery stenosis. Tenecteplase dosage: Unk. During the same period patient was treated with ENOXAPARIN SODIUM (Unk) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), CLOPIDOGREL (Unk) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6279241-7 | Aphasia, Asthenia, Cerebral Haemorrhage, Condition Aggravated, Facial Paresis, Hypoaesthesia
Patient was taking Tenecteplase (View Usage). After Tenecteplase was administered, patient had the following side effects: aphasia (What is aphasia?), asthenia, cerebral haemorrhage, condition aggravated, facial paresis, hypoaesthesia on Jul 20, 2009 from UNITED STATES Additional patient health information: Female patient , 46 years of age, weighting 119.0 lb, was diagnosed with ischaemic stroke and. Tenecteplase dosage: 49mg -0.9mg/kg- One Time Iv. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

6269549-3 | Circulatory Collapse, Mucosal Haemorrhage
Adverse event was reported on Jul 03, 2009 by a Male patient taking Tenecteplase (View Usage) (Dosage: 50 Mg, Single) was diagnosed with pulmonary embolism (What is pulmonary embolism?) and. Location: GERMANY , weighting 264.6 lb, Patient experienced the following unwanted or unexpected effects: circulatory collapse, mucosal haemorrhage. During the same period patient was treated with FONDAPARINUX SODIUM (10 Mg, Single) (View Fondaparinux Sodium Review and Fondaparinux Sodium Label ), ZINACEF (750 Mg, X1) (View Zinacef Review and Zinacef Label ), METOPROLOL TARTRATE (12.5 Mg, X1) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ADRENALINE (12 Mg, Continuous) (View Adrenaline Review and Adrenaline Label ), ATROPINE (3 Mg, X1) (View Atropine Review and Atropine Label ).

6176599-4 | Aphasia, Cerebrovascular Accident, Haemorrhage Intracranial
on Apr 22, 2009 Male patient from UNITED STATES , 66 years of age, weighting 170.0 lb, was diagnosed with cerebrovascular accident, prophylaxis and was treated with Tenecteplase (View Usage). Patient had the following side effects: aphasia (What is aphasia?), cerebrovascular accident, haemorrhage intracranial. Tenecteplase dosage: Unk. During the same period patient was treated with AGGRENOX (25/200 Mg, Bid) (View Aggrenox Review and Aggrenox Label ), LIPITOR (10 Mg, Qd) (View Lipitor Review and Lipitor Label ), VERAPAMIL EXTENDED RELEASE (120 Mg, Qd) (View Verapamil Extended-release Review and Verapamil Extended-release Label ). Patient was hospitalized and became disabled.

6168864-1 | Bacteraemia
on Apr 20, 2009 Female patient from UNITED STATES , weighting 152.6 lb, was diagnosed with indwelling catheter management, hypertension, hyperphosphataemia, diabetes mellitus and was treated with Tenecteplase (View Usage). After Tenecteplase was administered, patient had the following side effects: bacteraemia. Tenecteplase dosage: . During the same period patient was treated with COZAAR (Unk, Unk) (View Cozaar Review and Cozaar Label ), HUMALOG (View Humalog Review and Humalog Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), RENAGEL (Unk, Unk) (View Renagel Review and Renagel Label ), RENAL CAPS (View Renal Caps Review and Renal Caps Label ), SENSIPAR (View Sensipar Review and Sensipar Label ), HUMULIN R (Unk, Unk) (View Humulin R Review and Humulin R Label ). Patient was hospitalized.

5773115-3 | Staphylococcal Bacteraemia
Patient was taking Tenecteplase (View Usage). Patient experienced the following unwanted or unexpected effects: staphylococcal bacteraemia on Jun 06, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 117.5 lb, was diagnosed with indwelling catheter management, hypermagnesaemia, hypercalcaemia, analgesia, anxiety (What is anxiety?) and. Tenecteplase dosage: 2 Ml, Unk. During the same period patient was treated with MAGNA BIND (UNK INGREDIENTS) (View Magna Bind (unk Ingredients) Review and Magna Bind (unk Ingredients) Label ), NEPHRO VITE (View Nephro-vite Review and Nephro-vite Label ), CALCIUM SALTS NOS (View Calcium Salts Nos Review and Calcium Salts Nos Label ), CINACALCET HYDROCHLORIDE (View Cinacalcet Hydrochloride Review and Cinacalcet Hydrochloride Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

5747023-8 | Bacteraemia
Adverse event was reported on May 14, 2008 by a Female patient taking Tenecteplase (View Usage) (Dosage: ) was diagnosed with indwelling catheter management, hypertension, hyperphosphataemia, diabetes mellitus and. Location: UNITED STATES , weighting 152.6 lb, Patient had the following side effects: bacteraemia. During the same period patient was treated with COZAAR (Unk, Unk) (View Cozaar Review and Cozaar Label ), HUMALOG (View Humalog Review and Humalog Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), RENAGEL (Unk, Unk) (View Renagel Review and Renagel Label ), RENAL CAPS (View Renal Caps Review and Renal Caps Label ), SENSIPAR (View Sensipar Review and Sensipar Label ), HUMULIN R (Unk, Unk) (View Humulin R Review and Humulin R Label ). Patient was hospitalized.

5740440-1 | Bacteraemia
on May 09, 2008 Female patient from UNITED STATES , weighting 152.6 lb, was diagnosed with indwelling catheter management and was treated with Tenecteplase (View Usage). After Tenecteplase was administered, patient had the following side effects: bacteraemia. Tenecteplase dosage: 2 Ml, Unk. During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ), HUMALOG (View Humalog Review and Humalog Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), RENAGEL (View Renagel Review and Renagel Label ), RENAL CAPS (View Renal Caps Review and Renal Caps Label ), SENSIPAR (View Sensipar Review and Sensipar Label ). Patient was hospitalized.

5451566-4 | Ventricular Fibrillation
on Sep 11, 2007 Male patient from , 37 years of age, was diagnosed with acute myocardial infarction, chest pain (What is chest pain?) and was treated with Tenecteplase (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular fibrillation. Tenecteplase dosage: . During the same period patient was treated with COCAINE (View Cocaine Review and Cocaine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ), PETHIDINE (View Pethidine Review and Pethidine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

5119638-1 | Pancreatic Carcinoma
Patient was taking Tenecteplase (View Usage). Patient had the following side effects: pancreatic carcinoma on Sep 21, 2006 from AUSTRIA Additional patient health information: Male patient , 73 years of age, was diagnosed with acute myocardial infarction and. Tenecteplase dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

5104137-3 | Electromechanical Dissociation, Pulmonary Embolism
Adverse event was reported on Aug 25, 2006 by a Male patient taking Tenecteplase (View Usage) (Dosage: 45 Mg, Single, Iv Bolus) was diagnosed with cardiac arrest (What is cardiac arrest?) and. Location: NETHERLANDS , 66 years of age, After Tenecteplase was administered, patient had the following side effects: electromechanical dissociation, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with ACENOCOUMAROL (ACENOCOUMAROL) (View Acenocoumarol (acenocoumarol) Review and Acenocoumarol (acenocoumarol) Label ), SOTALOL HYDROCHLORIDE (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ).

5081392-X | Hypotension, Lower Gastrointestinal Haemorrhage
on Aug 14, 2006 Female patient from UNITED STATES , 72 years of age, was treated with Tenecteplase (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, lower gastrointestinal haemorrhage. Tenecteplase dosage: . During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), EPTIFIBATIDE (View Eptifibatide Review and Eptifibatide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5080566-1 | Gastrointestinal Haemorrhage
on Aug 14, 2006 Female patient from UNITED STATES , 65 years of age, was treated with Tenecteplase (View Usage). Patient had the following side effects: gastrointestinal haemorrhage. Tenecteplase dosage: See Image. During the same period patient was treated with ENOXAPARIN SODIUM (See Image) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), TIROFIBAN (View Tirofiban Review and Tirofiban Label ). Patient was hospitalized.

5011117-5 | Activated Partial Thromboplastin Time Prolonged, Cerebral Haemorrhage, Electrocardiogram St Segment Elevation, Loss Of Consciousness, Pupil Fixed, Snoring
Patient was taking Tenecteplase (View Usage). After Tenecteplase was administered, patient had the following side effects: activated partial thromboplastin time prolonged, cerebral haemorrhage, electrocardiogram st segment elevation, loss of consciousness, pupil fixed, snoring (What is snoring?) on May 23, 2006 from UNITED STATES Additional patient health information: Male patient , 64 years of age, was diagnosed with myocardial infarction and. Tenecteplase dosage: . Patient was hospitalized.

4785971-6 | Abdominal Pain, Aortic Dissection, Aortic Rupture, Hypotension, Intermittent Claudication, Ischaemia, Livedo Reticularis, Pain In Extremity
Adverse event was reported on Sep 30, 2005 by a Male patient taking Tenecteplase (View Usage) (Dosage: 0.5mg/hour Continuous Intra-arte) was diagnosed with embolism and. Location: UNITED STATES , 83 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), aortic dissection, aortic rupture, hypotension, intermittent claudication, ischaemia, livedo reticularis, pain in extremity. During the same period patient was treated with HEPARIN (400 Units/hour Continuous Intra-arte) (View Heparin Review and Heparin Label ), FLOVENT (View Flovent Review and Flovent Label ), MORPHINE (View Morphine Review and Morphine Label ), ALBUTEROL/ATROVENT (View Albuterol/atrovent Review and Albuterol/atrovent Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ), AVAPRO (View Avapro Review and Avapro Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), CALAN (View Calan Review and Calan Label ).

4631135-6 | Cerebellar Haemorrhage
on Apr 07, 2005 Female patient from , 65 years of age, weighting 134.5 lb, was diagnosed with myocardial infarction and was treated with Tenecteplase (View Usage). Patient had the following side effects: cerebellar haemorrhage. Tenecteplase dosage: 35mg. During the same period patient was treated with EPTIFIBATIDE (161.2mg) (View Eptifibatide Review and Eptifibatide Label ).